Navigation Links
QIAGEN Offers Clinical Labs Early Access to New Ingenuity Solution for Streamlined Interpretation of Patient Sequencing Data
Date:11/13/2013

inical interpretation solution at the AMP annual meeting in exhibition stand 1016 and in a corporate workshop on Wednesday, November 13. For more information please visit http://www.ingenuity.com/AMP-2013

About QIAGEN Redwood City

QIAGEN Redwood City, formerly Ingenuity Systems, is based in Redwood City, California. As the company's Center of Excellence in Biological Analysis and Interpretation, QIAGEN Redwood City is a leading provider of biomedical information and analysis solutions for the exploration, interpretation and analysis of complex biological systems in life science research and now moving towards molecular diagnostics. Marketed under the Ingenuity brand, these innovative solutions offered by QIAGEN are used by tens of thousands of researchers and clinicians at hundreds of leading pharmaceutical, biotechnology, academic, and clinical institutions worldwide. Further information can be found at http://www.qiagen.com/ingenuity

About QIAGEN

QIAGEN N.V. is a Netherlands holding company publically traded on NASDAQ and Frankfurt Prime Standard. The Company is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular insights. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are then used to make these isolated biomolecules visible and ready for interpretation. QIAGEN markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). As of September 30,
'/>"/>

SOURCE Qiagen N.V.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Financial Results, Appointments, Earnings Conferences, and Partnerships - Research Report on New Oriental Education & Technology, Acacia Research, DeVry, Capella Education, and Qiagen NV
2. Exosome Diagnostics and QIAGEN Partner to Launch Comprehensive Line of Biofluid Nucleic Acid Kits to Address Limitations of Tissue Biopsy in Clinical Research Market
3. QIAGEN Significantly Expands its Offering of Assay Panels for Next-generation Sequencing (NGS) Complemented by Ingenuity Analysis and Interpretation Capabilities
4. QIAGEN Expands Pipeline of Promising New Biomarkers for Development of Personalized Healthcare Companion Diagnostics
5. QIAGEN Enters Into Broad Collaboration Agreement With Lilly for the Development and Commercialization of Companion Diagnostics
6. QIAGEN Kicks Off Next-Generation Sequencing Initiative With Launch of a Series of Consumable Products to Improve NGS Workflows
7. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
8. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
9. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
10. Pediatric Group Offers Consistent Vision Care Across Its Network with Spot Vision Screener
11. Dr. George O. Gavrila Opens Baltimore Tattoo Removal, Offers Astanza Duality Laser Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 5, 2015  Vaccinogen, Inc. (OTC.QB: VGEN), a ... of Directors has unanimously elected Co-founder, President, Chief Executive ... to the role of Chairman of the Board. Mr. ... who resigned from the Board and his role as ... role to pursue his candidacy for the President of ...
(Date:5/5/2015)... Bio-Techne Corporation (NASDAQ: TECH ) announced ... a dividend of $0.32 per share for the quarter ... payable May 29, 2015 to all common shareholders of ... be considered by the Board of Directors on a ... ) is a global life sciences company providing innovative ...
(Date:5/5/2015)... , May 05, 2015 Research and Markets ... of the "Will Theranos Turn the Lab Industry ... Theranos has received much praise along with a healthy ... "gone public" with their potentially disruptive laboratory solution. Behind ... Has Theranos scaled microfluidic technology across a ...
Breaking Medicine Technology:Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board 2Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board 3Will Theranos Turn the Lab Industry Upside Down? 2
... Mass. , June 1 SynapDx Corp., a new company ... autism, announced the completion of a $9 million Series A ... Partners. , , , ... profound effect on children and their families," said Stanley N. Lapidus ...
... FRANCISCO , June 1 Prostate cancer ... FIRMAGON® (degarelix for injection) after one year of treatment ... of a Phase III extension study(1) presented here at ... used in monitoring prostate cancer patients, treatment response, and ...
Cached Medicine Technology:Extension Study With FIRMAGON® (degarelix) Showed Continued Benefits for Prostate Cancer Patients Beyond One Year 2Extension Study With FIRMAGON® (degarelix) Showed Continued Benefits for Prostate Cancer Patients Beyond One Year 3Extension Study With FIRMAGON® (degarelix) Showed Continued Benefits for Prostate Cancer Patients Beyond One Year 4Extension Study With FIRMAGON® (degarelix) Showed Continued Benefits for Prostate Cancer Patients Beyond One Year 5
(Date:5/5/2015)... 2015 In the upbeat Moms Helping Moms ... moms to support each other. Parenting is a tough ... makes it so much easier. Mothers talk about how ... less alone and help them realize there’s no perfect parent; ... who are clearly dear friends share that it's just that, ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Specialty ... collaborating with American Eagle Outfitters on a collection ... natural beauty. , For the debut five-piece ... Aerie by American Eagle ; the retailer's ... body-image campaign, called "Aerie REAL," uses models of ...
(Date:5/5/2015)... 05, 2015 Igantia , an ... leads an international initiative to examine key biological milestones ... human lifespan. Scientists at Igantia believe that better ... the initiation of her menstrual cycle to her transition ... aging and, ultimately, extend the lifespan. , By ...
(Date:5/5/2015)... 05, 2015 Care Logistics ... called “Medicare Breakeven Challenges? A Model to ... ,     Formulas for two critical ... but should be ,     A model ... space” and ensures sustained efficient operations , ...
(Date:5/5/2015)... 05, 2015 Every year, news articles appear ... out, the worst dry eye season is spring, also known ... most of the United States. The only season offering a ... Sharon Kleyne, host of the Sharon Kleyne Hour™ Power of ... radio show of May 11, 2015. Kleyne is the inventor ...
Breaking Medicine News(10 mins):Health News:Just In Time For Mother’s Day, Healthy Birth Day Releases Video Titled “Moms Helping Moms” Encouraging Mothers To Band Together 2Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 2Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 3Health News:Igantia Announces Digital Initiative to Decode Longevity 2Health News:Care Logistics Publishes a New Hospital Guidebook for Achieving Medicare Breakeven 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 3
... Unfortunately for us, there is no formula for fulfillment or ... religion and science time and again for answers to our ... Confucius and Plato, and science continues to piece together some ... Psychologists Nansook Park and Christopher Peterson from the University ...
... at Massachusetts General Hospital (MGH) has been awarded $15 ... Diseases to investigate how the hepatitis C virus (HCV) ... The five-year grant will support a Cooperative Center for ... on how some individuals successfully recover from HCV while ...
... network of medical research institutions across the United States ... to gather critical data about influenza vaccines, including two ... the direction of the National Institute of Allergy and ... Health. "With the emergence of the 2009 ...
... ROSEMONT, Ill., July 22 The American Academy of Orthopaedic ... the treatment of pediatric diaphyseal femur fractures . ... (the bone in the thigh) is a very common childhood injury. ... treatment options for femur fracture, a thighbone injury occurring in an ...
... , WASHINGTON, July 22 ... Medical Doctors Alfred Bonati, M.D., participated yesterday in ... Committee Chairman Michael Steele. Dr. Bonati and other attendees from ... impact of health-care reform on physicians, small businesses, employees and ...
... PHILADELPHIA, July 22 New research from The Children,s ... in acting as gatekeepers for infectious viruses. By using mice genetically ... the study team prevented infection by a common virus that causes ... "This finding is a step to understanding how cell receptors ...
Cached Medicine News:Health News:Life lessons: Where psychology stands on living well 2Health News:Mass. General-based research center will investigate why immune system fails to control hepatitis C 2Health News:NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidates 2Health News:NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidates 3Health News:American Academy of Orthopaedic Surgeons Approves New Guideline for the Treatment of Pediatric Diaphyseal Femur Fractures 2Health News:American Academy of Orthopaedic Surgeons Approves New Guideline for the Treatment of Pediatric Diaphyseal Femur Fractures 3Health News:American Academy of Orthopaedic Surgeons Approves New Guideline for the Treatment of Pediatric Diaphyseal Femur Fractures 4Health News:Internationally Renowned Surgeon Reaches out to RNC, Hispanic Community 2Health News:Eliminating Cell Receptor Prevents Infections in Animal Study 2Health News:Eliminating Cell Receptor Prevents Infections in Animal Study 3
Narrow smooth jaws. Serrated handle with polished finish....
1 mm smooth 45 degrees angled jaws. Cross action serrated handle with polished finish....
Round solid 15 mm wide lower plate. Open upper plate with inside diameter 12 mm. Serrated handle with locking thumb screw and polished finish....
Oval solid 17 mm wide lower plate. Open upper plate with inside dimensions 12 mm x 14 mm. Serrated handle with locking thumb screw and polished finish. Most popular size or model....
Medicine Products: